Pharmaceutical Research and Manufacturers of America

March 15, 2012—Legislation requiring state agencies to purchase their prescription drugs through the Oregon Prescription Drug Program (OPDP) once again was unable to overcome staunch opposition from the pharmaceutical industry and insurance lobbyists.